{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:41Z","timestamp":1791176801081,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health & Medical Research Council of Australia","award":["436823"],"award-info":[{"award-number":["436823"]}]}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijcard.2013.09.015","type":"journal-article","created":{"date-parts":[[2013,10,6]],"date-time":"2013-10-06T09:02:27Z","timestamp":1381050147000},"page":"281-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice"],"prefix":"10.1016","volume":"169","author":[{"given":"Sonja Tesanovic","family":"Kljajic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iresha","family":"Welungoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Bosnyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey A.","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2013.09.015_bb0005","first-page":"415","article-title":"International Union of Pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"4\u20135","key":"10.1016\/j.ijcard.2013.09.015_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0098-2997(00)00005-4","article-title":"Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction","volume":"21","author":"Keaney","year":"2000","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.RES.0000259393.89870.58","article-title":"Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation","author":"Libby","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2174\/0929867043365369","article-title":"Oxidative stress, antioxidants, and endothelial function","volume":"11","author":"Schulz","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0025","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/nm1102-1249","article-title":"Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies","volume":"8","author":"Dzau","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd873","article-title":"Drugs targeting the renin\u2013angiotensin\u2013aldosterone system","volume":"1","author":"Zaman","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0035","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","article-title":"Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice","volume":"110","author":"Wassmann","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2013.09.015_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","article-title":"AT2 receptors: functional relevance in cardiovascular disease","volume":"120","author":"Jones","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ijcard.2013.09.015_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705448","article-title":"Angiotensin AT2 receptors: cardiovascular hope or hype?","volume":"140","author":"Widdop","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.ijcard.2013.09.015_bb0050","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.yjmcc.2004.08.004","article-title":"Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade","volume":"37","author":"Jones","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.ijcard.2013.09.015_bb0055","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIRCULATIONAHA.104.525550","article-title":"Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice","volume":"112","author":"Iwai","year":"2005","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ijcard.2013.09.015_bb0060","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1161\/CIRCULATIONAHA.105.541714","article-title":"Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution","volume":"112","author":"Sales","year":"2005","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2013.09.015_bb0065","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor","volume":"110","author":"Daugherty","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2013.09.015_bb0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.yjmcc.2011.12.007","article-title":"Stimulation of the AT2 receptor reduced atherogenesis in ApoE(\u2212\/\u2212)\/AT1A(\u2212\/\u2212) double knock out mice","volume":"52","author":"Tiyerili","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.ijcard.2013.09.015_bb0080","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.hjh.0000174078.95745.77","article-title":"Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE\u2212\/\u2212 mice","volume":"23","author":"Johansson","year":"2005","journal-title":"J Hypertens"},{"issue":"10","key":"10.1016\/j.ijcard.2013.09.015_bb0085","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/01.hjh.0000244949.65040.de","article-title":"Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE\u2212\/\u2212 mice","volume":"24","author":"Johansson","year":"2006","journal-title":"J Hypertens"},{"issue":"14","key":"10.1016\/j.ijcard.2013.09.015_bb0090","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2013.09.015_bb0095","first-page":"61","article-title":"Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice","volume":"215","author":"Zhou","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ijcard.2013.09.015_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2007.10.037","article-title":"Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apoliporotein E deficient mice","volume":"199","author":"Blessing","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0105","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.CIR.0000121735.52471.AC","article-title":"Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity","volume":"109","author":"Cipollone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0110","first-page":"S22","article-title":"Identification and treatment of vulnerable plaque","volume":"5","author":"Nakamura","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0115","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","article-title":"Vasoprotective and atheroprotective effects of angiotensin (1\u20137) in apolipoprotein E-deficient mice","volume":"30","author":"Tesanovic","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.ijcard.2013.09.015_bb0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/cvr\/cvm021","article-title":"Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice","volume":"77","author":"Vinh","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.FMJ04006X6","article-title":"Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis","volume":"96","author":"Kawashima","year":"2004","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.ijcard.2013.09.015_bb0130","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.HYP.0000164571.77710.19","article-title":"Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension","volume":"45","author":"Hiyoshi","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ijcard.2013.09.015_bb0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2007.11.006","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression","volume":"199","author":"Hu","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ijcard.2013.09.015_bb0140","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.HYP.0000244108.30909.27","article-title":"Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor","volume":"48","author":"Yayama","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ijcard.2013.09.015_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","article-title":"apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant","volume":"51","author":"Heumuller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0155","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.ATV.0000097783.01596.E2","article-title":"Atherosclerotic plaque rupture: local or systemic process?","volume":"23","author":"Lutgens","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0160","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.ATV.0000014587.66321.B4","article-title":"Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice","volume":"2002","author":"Williams","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0165","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.HYP.36.5.845","article-title":"Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells","volume":"36","author":"Mifune","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.09.015_bb0170","first-page":"103","article-title":"Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling","volume":"24","author":"Jing","year":"2009","journal-title":"Int J Mol Med"},{"issue":"12","key":"10.1016\/j.ijcard.2013.09.015_bb0175","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.ijcard.2013.09.015_bb0180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.109.147843","article-title":"Direct angiotensin II Type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor {kappa}B","volume":"55","author":"Rompe","year":"2010","journal-title":"Hypertension"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313017993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313017993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T10:54:10Z","timestamp":1539341650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313017993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0167527313017993"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.09.015","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}